| 英文名称 |
中文名称 |
CAS |
|
NLRP3/AIM2-IN-2
|
|
791840-86-3 |
|
TBG Protein, Human, Recombinant (His)
|
|
|
|
NNGH
|
|
161314-17-6 |
|
Pseudoginsenoside RT1
|
|
98474-74-9 |
|
WAY-639228
|
|
179051-05-9 |
|
Ciproquazone
|
|
33453-23-5 |
|
Minamestane
|
|
105051-87-4 |
|
CB2R/FAAHmodulator-2
|
|
2876918-68-0 |
|
FcRH5/FcRL5 Protein, Human, Recombinant (His)
|
|
|
|
SN50 TFA
|
|
|
|
Oleic Acid-2,6-diisopropylanilide
|
|
140112-65-8 |
|
BPHA
|
|
193807-60-2 |
|
Navamepent
|
|
1251537-11-7 |
|
Metamitron
|
|
41394-05-2 |
|
BTYNB
|
|
304456-62-0 |
|
TRPM4-IN-1
|
|
351424-20-9 |
|
p53-Mdm2 inhibitor 4
|
|
350678-63-6 |
|
1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC
|
|
154436-48-3 |
|
(E/Z)-IT-603
|
|
292168-90-2 |
|
VH 032 amide-PEG1-acid
|
|
2172820-07-2 |
|
Myristoyl glutamic acid sodium
|
|
38517-37-2 |
|
5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate
|
|
127770-45-0 |
|
15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide
|
|
1163135-96-3 |
|
20-O-Glucoginsenoside Rf
|
|
68406-27-9 |
|
N-terminally acetylated Leu-enkephalin
|
|
|
|
9-Cyclopentyladenine
|
|
715-91-3 |
|
1-Stearoyl-sn-glycero-3-phosphocholine
|
|
19420-57-6 |
|
Linuron
|
|
330-55-2 |
|
TH1760
|
|
2567914-01-4 |
|
Vedaprofen
|
|
71109-09-6 |
|
AWL-II-38.3
|
|
1135205-94-5 |
|
BIMU 8
|
|
134296-40-5 |
|
IL-15RA & IL-15 Protein, Human, Recombinant (hFc)
|
|
|
|
CD40 Protein, Human, Recombinant (His)
|
|
|
|
Pantothenate Kinase Inhibitor
|
|
902614-04-4 |
|
MS31 trihydrochloride (2366264-12-0 free base)
|
|
|
|
Idarubicin hydrochloride
|
|
57852-57-0 |
|
BI-0115
|
|
4929-23-1 |
|
M-31850
|
|
281224-40-6 |
|
HDAC1/5-IN-1
|
|
380463-49-0 |
|
5-(Biotinamido)pentylamine
|
|
115416-38-1 |
|
HTS07545
|
|
118666-03-8 |
|
Z16078526
|
|
852222-94-7 |
|
Senktide acetate
|
|
|
|
D-Xylofuranose, 1,2,3,5-tetraacetate
|
|
42927-46-8 |
|
Capeserod
|
|
769901-96-4 |
|
Thalidomide 4-fluoride
|
|
835616-60-9 |
|
(±)13(14)-EpDPA
|
|
895127-64-7 |
|
γ-Glu-Tyr
|
|
7432-23-7 |
|
AST 7062601
|
|
675197-89-4 |
|
LASV inhibitor 3.3
|
|
554438-52-7 |
|
Oxyphenonium bromide
|
|
50-10-2 |
|
1,1'-Methylenedi-2-naphthol
|
|
1096-84-0 |
|
CHEMBL1276927
|
|
305357-89-5 |
|
rCRAMP (rat) acetate
|
|
|
|
Oxamisole TFA
|
|
|
|
C14 Ceramide (d18:1/14:0)
|
|
34227-72-0 |
|
HOIPIN-1
|
|
2470242-33-0 |
|
Cassiaside
|
|
13709-03-0 |
|
Glycerophosphorylethanolamine (sodium salt)
|
|
883288-78-6 |
|
TNIK-IN-2
|
|
2754265-76-2 |
|
(S)-nitro-Blebbistatin
|
|
856925-75-2 |
|
cis-4-Hydroxy-L-proline
|
|
618-27-9 |
|
2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid
|
|
1053228-28-6 |
|
Baminercept
|
|
909110-25-4 |
|
3-methyl-1,2,3,4-tetrahydroquinazolin-2-one
|
|
24365-65-9 |
|
9(S)-HODE cholesteryl ester
|
|
143442-54-0 |
|
Fenclozic acid
|
|
17969-20-9 |
|
SNX7
|
|
685097-43-2 |
|
Compound T37349(SC)
|
|
57966-95-7 |
|
Arachidonoyl thio-PC
|
|
146797-82-2 |
|
RO 5263397 hydrochloride
|
|
|
|
5-(2-furyl)-N-propylisoxazole-3-carboxamide
|
|
907989-92-8 |
|
Carboxylesterase-IN-3
|
|
2764748-92-5 |
|
Oncostatin M/OSM Protein, Mouse, Recombinant
|
|
|
|
21-deacetyldeflazacort
|
|
13649-57-5 |
|
Platensimycin
|
|
835876-32-9 |
|
SYR127063
|
|
871026-18-5 |
|
Substance P (1-7) 2TFA(68060-49-1(free base))
|
|
|
|
3-Methoxysalicylaldehyde
|
|
148-53-8 |
|
CCT241533 dihydrochloride
|
|
1962925-28-5 |
|
Mezlocillin Sodium
|
|
42057-22-7 |
|
C004019
|
|
2417159-57-8 |
|
EGFR-IN-87
|
|
1835666-87-9 |
|
3MB-PP1
|
|
956025-83-5 |
|
Sanguisorbigenin
|
|
6812-98-2 |
|
2,3,4,5-Tetrachlorophenol
|
|
4901-51-3 |
|
(E/Z)-Elafibranor
|
|
824932-88-9 |
|
WWL 154
|
|
1338574-93-8 |
|
Otilimab
|
|
1638332-55-4 |
|
Desmorpholinyl Navitoclax-NH-Me
|
|
2365172-82-1 |
|
Tz-Thalidomide
|
|
2087490-42-2 |
|
IL-15RA Protein, Mouse, Recombinant (hFc, Human Cells)
|
|
|
|
Alpha-Synuclein Protein, Human, Recombinant
|
|
|
|
Regaloside C
|
|
117591-85-2 |
|
Guan-fu base A hydrochloride(1394-48-5 free base)
|
|
618094-85-2 |
|
Pinolenic Acid
|
|
16833-54-8 |
|
(±)10(11)-DiHDPA
|
|
1345275-22-0 |
|
Neochlorogenic acid methyl ester
|
|
123410-65-1 |
|
CBS1117
|
|
959245-08-0 |
